Suppr超能文献

了解与普通人群相比,因 COVID-19 住院的智力残疾患者的结局不平等情况:英国一项匹配队列研究。

Understanding inequalities in COVID-19 outcomes following hospital admission for people with intellectual disability compared to the general population: a matched cohort study in the UK.

机构信息

Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK

The LonDowns Consortium, London, UK.

出版信息

BMJ Open. 2021 Oct 4;11(10):e052482. doi: 10.1136/bmjopen-2021-052482.

Abstract

OBJECTIVES

This study explores the hospital journey of patients with intellectual disabilities (IDs) compared with the general population after admission for COVID-19 during the first wave of the pandemic (when demand on inpatient resources was high) to identify disparities in treatment and outcomes.

DESIGN

Matched cohort study; an ID cohort of 506 patients were matched based on age, sex and ethnicity with a control group using a 1:3 ratio to compare outcomes from the International Severe Acute Respiratory and emerging Infections Consortium WHO Clinical Characterisation Protocol UK.

SETTING

Admissions for COVID-19 from UK hospitals; data on symptoms, severity, access to interventions, complications, mortality and length of stay were extracted.

INTERVENTIONS

Non-invasive respiratory support, intubation, tracheostomy, ventilation and admission to intensive care units (ICU).

RESULTS

Subjective presenting symptoms such as loss of taste/smell were less frequently reported in ID patients, whereas indicators of more severe disease such as altered consciousness and seizures were more common. Controls had higher rates of cardiovascular risk factors, asthma, rheumatological disorder and smoking. ID patients were admitted with higher respiratory rates (median=22, range=10-48) and were more likely to require oxygen therapy (35.1% vs 28.9%). Despite this, ID patients were 37% (95% CI 13% to 57%) less likely to receive non-invasive respiratory support, 40% (95% CI 7% to 63%) less likely to receive intubation and 50% (95% CI 30% to 66%) less likely to be admitted to the ICU while in hospital. They had a 56% (95% CI 17% to 102%) increased risk of dying from COVID-19 after they were hospitalised and were dying 1.44 times faster (95% CI 1.13 to 1.84) compared with controls.

CONCLUSIONS

There have been significant disparities in healthcare between people with ID and the general population during the COVID-19 pandemic, which may have contributed to excess mortality in this group.

摘要

目的

本研究旨在探讨在大流行的第一波疫情期间(当时住院资源需求很高),与普通人群相比,因 COVID-19 住院的智力障碍(ID)患者的住院经历,以确定治疗和结局方面的差异。

设计

匹配队列研究;根据年龄、性别和种族,将 506 名 ID 患者与对照组进行匹配,比例为 1:3,以比较国际严重急性呼吸与新兴感染联盟世卫组织临床特征方案英国的数据。

地点

英国医院收治的 COVID-19 患者;提取症状、严重程度、干预措施的获取、并发症、死亡率和住院时间的数据。

干预措施

非侵入性呼吸支持、插管、气管切开术、通气和转入重症监护病房(ICU)。

结果

ID 患者较少报告味觉/嗅觉丧失等主观首发症状,而意识改变和癫痫等更严重疾病的指标则更为常见。对照组患者具有更高的心血管危险因素、哮喘、风湿性疾病和吸烟率。ID 患者的呼吸频率更高(中位数=22,范围=10-48),更有可能需要吸氧治疗(35.1% vs 28.9%)。尽管如此,ID 患者接受非侵入性呼吸支持的可能性降低了 37%(95%可信区间 13%至 57%),接受插管的可能性降低了 40%(95%可信区间 7%至 63%),住院期间转入 ICU 的可能性降低了 50%(95%可信区间 30%至 66%)。他们在住院后死于 COVID-19 的风险增加了 56%(95%可信区间 17%至 102%),与对照组相比,他们的死亡速度快了 56%(95%可信区间 1.13 至 1.84)。

结论

在 COVID-19 大流行期间,智障患者与普通人群之间的医疗保健存在显著差异,这可能导致该人群的死亡率增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd12/8491000/dcdb4cd45e1b/bmjopen-2021-052482f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验